{"id":556648,"date":"2026-06-04T22:45:51","date_gmt":"2026-06-04T20:45:51","guid":{"rendered":"https:\/\/medizinonline.com\/?p=556648"},"modified":"2026-06-01T11:05:22","modified_gmt":"2026-06-01T09:05:22","slug":"destiny-breast11-t-dxd-neoadjuvant-sans-anthracyclines","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/fr\/destiny-breast11-t-dxd-neoadjuvant-sans-anthracyclines\/","title":{"rendered":"DESTINY-Breast11 &#8211; T-DXd n\u00e9oadjuvant sans anthracyclines"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>L&#8217;\u00e9tude de phase III DESTINY-Breast11 montre que le trastuzumab-deruxtecan (T-DXd) n\u00e9oadjuvant pourrait offrir une option de traitement sans anthracycline pour le cancer du sein pr\u00e9coce HER2-positif. Les r\u00e9sultats sugg\u00e8rent une alternative \u00e0 la fois efficace et mieux tol\u00e9r\u00e9e aux sch\u00e9mas standard contenant des anthracyclines. <\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/fr\/mon-compte\/paquets\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/fr\/se-connecter\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Ffr%2Fdestiny-breast11-t-dxd-neoadjuvant-sans-anthracyclines%2F\">Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>L&#8217;\u00e9tude de phase III DESTINY-Breast11 montre que le trastuzumab-deruxtecan (T-DXd) n\u00e9oadjuvant pourrait offrir une option de traitement sans anthracycline pour le cancer du sein pr\u00e9coce HER2-positif. Les r\u00e9sultats sugg\u00e8rent une&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/fr\/mon-compte\/paquets\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/fr\/se-connecter\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Ffr%2Fdestiny-breast11-t-dxd-neoadjuvant-sans-anthracyclines%2F\">Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":556649,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Cancer du sein pr\u00e9coce HER2","footnotes":""},"category":[11549,11527,11531,11422,11389],"tags":[92402,92406,92413,13591,92407,92401,92428,90847,92430,92426,92404,92399,92414,16468,92423,92419,92427,92422,92425,13600,92410,92421,92416,92429,54683,92412,23622,55481,92400,92424,92408,92409,72787,90848,92405,92415,92418,92417,92420,92411,92403],"powerkit_post_featured":[],"class_list":["post-556648","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rx-fr","category-etudes","category-formation-continue","category-gynecologie","category-oncologie","tag-adc-cancer-du-sein","tag-anticorps-ciblant-her2","tag-approche-sans-anthracycline","tag-cancer-du-sein","tag-cancer-du-sein-her2-positif-2","tag-cancer-du-sein-precoce-her2-positif","tag-cardiotoxicite-anthracyclines","tag-conjugue-anticorps-medicament","tag-consensus-de-saint-gall","tag-ddac-thp","tag-destiny-breast03","tag-destiny-breast11","tag-efs","tag-her2-fr","tag-metastases-cerebrales-cancer-du-sein","tag-metastases-leptomeningees","tag-neutropenies-severes","tag-oncologie-suisse","tag-paclitaxel-plus-double-blocage-de-her2","tag-pfs-fr","tag-remission-complete-pathologique","tag-schema-de-traitement-par-anthracycline-a-dose-condensee","tag-schema-de-traitement-sans-anthracycline","tag-securite-t-dxd","tag-survie-globale","tag-survie-sans-evenement","tag-survie-sans-progression","tag-t-dm1-fr","tag-t-dxd","tag-t-dxd-efficacite","tag-t-dxd-en-monotherapie","tag-t-dxd-neoadjuvant","tag-taux-de-pcr","tag-therapie-adc","tag-therapie-ciblee-sur-her2","tag-therapie-thp","tag-toxicite-cardiaque","tag-toxicite-hematologique","tag-traitement-contenant-de-la-t-dxd-anthracycline","tag-traitement-neoadjuvant-her2-positif","tag-trastuzumab-deruxtecan","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-07-03 22:31:28","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"fr_FR","wpml_translations":{"it_IT":{"locale":"it_IT","id":556645,"slug":"destiny-breast11-t-dxd-neoadiuvante-senza-antracicline","post_title":"DESTINY-Breast11 - T-DXd neoadiuvante senza antracicline","href":"https:\/\/medizinonline.com\/it\/destiny-breast11-t-dxd-neoadiuvante-senza-antracicline\/"},"pt_PT":{"locale":"pt_PT","id":556714,"slug":"destiny-breast11-t-dxd-neoadjuvante-sem-antraciclinas","post_title":"DESTINY-Breast11 - T-DXd neoadjuvante sem antraciclinas","href":"https:\/\/medizinonline.com\/pt-pt\/destiny-breast11-t-dxd-neoadjuvante-sem-antraciclinas\/"},"es_ES":{"locale":"es_ES","id":556758,"slug":"destiny-breast11-t-dxd-neoadyuvante-sin-antraciclinas","post_title":"DESTINY-Breast11 - T-DXd neoadyuvante sin antraciclinas","href":"https:\/\/medizinonline.com\/es\/destiny-breast11-t-dxd-neoadyuvante-sin-antraciclinas\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/556648","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/comments?post=556648"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/556648\/revisions"}],"predecessor-version":[{"id":556650,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/556648\/revisions\/556650"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media\/556649"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media?parent=556648"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/category?post=556648"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/tags?post=556648"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/powerkit_post_featured?post=556648"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}